Health Care: Drugs

Medivation Inc (MDVN: NASDAQ)

$112.06 -0.44 | -0.39%
07/02/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 112.06
52 Week High 141.58
52 Week Low 69.11
Avg. Daily Vol. (Mil) 0.93
Beta (3 year) 0.64
Share Related Items
Mkt Cap (Mil) 8,818.45
Shares Out (Mil) 78.69
Float (Mil) 65.90
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.70
Current Ratio 7.00
LT Debt/ Equity 0.52
Total Debt / Equity 0.52
Valuation Ratios
Price Earnings 33.20
Price/Sales 11.72
Price/Book 18.72
Price/Cash Flow 29.70
Per Share Data
Earnings 3.38
Sales 9.56
Book Value 5.99
Cash Flow 3.77
Business Summary
Medivation Inc is a biopharmaceutical company engaged in the development of novel small molecule drugs to treat diseases like Alzheimer's disease and Huntington disease.
General Information
36th Floor, 525 Market Stree
San Francisco, CA 94105
www.medivation.net
Industry : Drugs
Sector: Health Care
Employees: 485
CEO: Dr. David T. Hung,M.D.
Short Interest
Current Month (Mil) 3.30
Previous Month (Mil) 3.60
Short Interest Ratio (Days) 3.50
Management Effectiveness
Return on Equity 60.90
Return on Assets 31.00
Return on Investments 40.10
Profitability
Gross Margin n.a.
EBIT Margin 37.40
Profit Margin 38.10

Portfolios with MDVN

Latest MDVN Headlines from TheStreet

More Financial News for MDVN

Press Releases for MDVN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter